Project Grant N002441510060

The Defense Health Agency awarded Jhpiego Corporation $933,052 under a Cooperative Agreement from October 1, 2021 to September 30, 2023 to support the Department of Defense HIV/AIDS Prevention Program. As part of this award, Jhpiego will provide reproductive, maternal, newborn, child, and adolescent health services, family health and nutrition activities, voluntary medical male circumcision and pre-exposure prophylaxis services, and health system performance improvement efforts to the Botswana...

This Project Grant award of $160,000 from the Department of State Bureau of African Affairs supports efforts by Adpp Angola under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) Programs (CFDA 19.029) to prevent mother-to-child transmission of HIV in Angola. Key deliverables include strengthening HIV care and treatment at health facilities, increasing community engagement, and building clinical laboratory and supply chain infrastructure from August 6, 2021 to September 30, 2021....

This Cooperative Agreement award of $100,000 from the Department of State Bureau of African Affairs will support Health Development Consultancy Services (Hedecs) to improve HIV service delivery and outcomes for key populations in eight regions of Cameroon through September 2023. Funded through the U.S. President's Emergency Plan for AIDS Relief Programs (PEPFAR; CFDA #19.029), Hedecs will identify and understand data-driven solutions to overcome barriers and ensure key populations receive...

The Defense Health Agency awarded a $272,000 cooperative agreement to Liga Colombiana De Lucha Contra El Sida to provide technical support for the management of Colombia's national response to sexually transmitted infections and HIV/AIDS with an emphasis on combined prevention for the military forces and national police from September 30, 2021 through September 29, 2022. The award supports the Department of Defense HIV/AIDS Prevention Program (CFDA 12.350), which provides training and assistance...

Federal Grant Award Summary Award Overview Harvard T.H. Chan School of Public Health received a $539,904 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct research on genomically informed morphological stromal signatures to predict lethal prostate cancer. The award was obligated on June 15, 2025, with a completion date of June 14, 2028, providing a three-year performance period for this biomedical research...

Federal Grant Award Summary Award Details: Carleton University received a $657,945 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2025, with a completion date of May 31, 2028. The award supports research titled "Predicting Later Differential DMD Patient Quality of Life of Distinct Corticosteroid Regimens via Serum Proteome and Steroid Hormone Profiling," conducted at the university's Ottawa,...

Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Washington University $4.88 million under the Military Medical Research and Development program (CFDA 12.420) on August 1, 2025, to develop and validate a novel point-of-care (POC) multiplex device for classifying molecular phenotypes of acute respiratory distress syndrome (ARDS) and sepsis. The four-year project, scheduled for completion by July 31, 2029, will deliver an innovative diagnostic technology capable of...

Metabiota, Inc. was awarded a $3.5 million cooperative agreement from the Defense Health Agency under the Department of Defense HIV/AIDS Prevention Program (CFDA 12.350) for the period of October 1, 2021 through September 30, 2023. The award will support Metabiota's efforts to build HIV epidemic control in Cameroon through strengthening HIV prevention, testing, linkage to care and treatment, and viral suppression programs within the Cameroon Defense Force. As part of this cooperative...

Federal Project Grant Award Summary Health Research, Inc. (operating as Health Research At Roswell Park) received a $958,389 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2026, through May 31, 2030. The award supports biomedical research initiatives designed to advance healthcare solutions for military service members and the American public. Based on Health Research, Inc.'s established portfolio...

Federal Grant Award Summary Health Research, Inc. (operating as Health Research At Roswell Park) received a $2.39 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2026, through May 31, 2030. This four-year award supports an epitranscriptomic research study investigating stress, lifestyle, and immune pathway mechanisms in aggressive breast cancer. The research initiative will be conducted at...